TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $998,000 | +59.2% | 9,535 | +70.3% | 0.09% | +35.9% |
Q2 2017 | $627,000 | -87.2% | 5,598 | -87.9% | 0.06% | -77.5% |
Q4 2016 | $4,881,000 | -26.2% | 46,370 | -22.6% | 0.28% | -8.4% |
Q3 2016 | $6,618,000 | +722.1% | 59,882 | +949.5% | 0.31% | +47.6% |
Q1 2015 | $805,000 | – | 5,706 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |